This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Lindstrom AB, Strynar MJ, Libelo EL. Polyfluorinated compounds: Past, present, and future. Environ Sci Technol 2011;45:7954–61. doi: 10.1021/es2011622LindstromABStrynarMJLibeloELPolyfluorinated compounds: Past, present, and future20114579546110.1021/es201162221866930Open DOISearch in Google Scholar
Giesy JP, Kannan K. Perfluorochemical surfactants in the environment. Environ Sci Technol 2002;36:146A-52A. doi: 10.1021/es022253tGiesyJPKannanKPerfluorochemical surfactants in the environment200236146A52A10.1021/es022253t11999053Open DOISearch in Google Scholar
Schecter A, Colacino J, Haffner D, Patel K, Opel M, Päpke O, Birnbaum L. Perfluorinated compounds, polychlorinated biphenyl, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA. Environ Health Perspect 2010;118:796–802. doi: 10.1289/ehp.0901347SchecterAColacinoJHaffnerDPatelKOpelMPäpkeOBirnbaumLPerfluorinated compounds, polychlorinated biphenyl, and organochlorine pesticide contamination in composite food samples from Dallas, Texas, USA201011879680210.1289/ehp.0901347289885620146964Open DOISearch in Google Scholar
Langer V, Dreyer A, Ebinghaus R. Polyfluorinated compounds in residential and nonresidential indoor air. Environ Sci Technol 2010;44:8075–81. doi: 10.1021/es102384zLangerVDreyerAEbinghausRPolyfluorinated compounds in residential and nonresidential indoor air20104480758110.1021/es102384z20925396Open DOISearch in Google Scholar
D’Eon JC, Mabury SA. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans? Environ Sci Technol 2011;45:7974–84. doi: 10.1021/es200171yD’EonJCMaburySAIs indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?20114579748410.1021/es200171y21630688Open DOISearch in Google Scholar
Nicole W. PFOA and cancer in a highly exposed community: New findings from the C8 science panel. Environ Health Perspect 2013;121:A340. doi: 10.1289/ehp.121-A340NicoleWPFOA and cancer in a highly exposed community: New findings from the C8 science panel2013121A34010.1289/ehp.121-A340385550724284021Open DOISearch in Google Scholar
Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, Goldman LR. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 2007;115:1670–6. doi: 10.1289/ehp.10334ApelbergBJWitterFRHerbstmanJBCalafatAMHaldenRUNeedhamLLGoldmanLRCord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth20071151670610.1289/ehp.10334207284718008002Open DOISearch in Google Scholar
Tao L, Kannan K, Wong CM, Arcaro KF, Butenhoff JL. Perfluorinated compounds in human milk from Massachusetts, USA. Environ Sci Technol 2008;42:3096–101. doi: 10.1021/es702789kTaoLKannanKWongCMArcaroKFButenhoffJLPerfluorinated compounds in human milk from Massachusetts, USA200842309610110.1021/es702789k18497172Open DOISearch in Google Scholar
von Ehrenstein OS, Fenton SE, Kato K, Kuklenyik Z, Calafat AM, Hines EP. Polyfluoroalkyl chemicals in the serum and milk of breastfeeding women. Reprod Toxicol 2009;27:239–45. doi: 10.1016/j.reprotox.2009.03.001vonEhrenstein OSFentonSEKatoKKuklenyikZCalafatAMHinesEPPolyfluoroalkyl chemicals in the serum and milk of breastfeeding women200927239–4510.1016/j.reprotox.2009.03.00119429402Open DOISearch in Google Scholar
Llorca M, Farré M, Picó Y, Teijón ML, Alvarez JG, Barceló D. Infant exposure of perfluorinated compounds: levels in breast milk and commercial baby food. Environ Int 2010;36:584–92. doi: 10.1016/j.envint.2010.04.016LlorcaMFarréMPicóYTeijónMLAlvarezJGBarcelóDInfant exposure of perfluorinated compounds: levels in breast milk and commercial baby food2010365849210.1016/j.envint.2010.04.01620494442Open DOISearch in Google Scholar
Brantsæter AL, Whitworth KW, Ydersbond TA, Haug LS, Haugen M, Knutsen HK, Thomsen C, Meltzer HM, Becher G, Sabaredzovic A, Hoppin JA, Eggesbø M, Longnecker MP. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ Int 2013;54:74–84. doi: 10.1016/j.envint.2012.12.014BrantsæterALWhitworthKWYdersbondTAHaugLSHaugenMKnutsenHKThomsenCMeltzerHMBecherGSabaredzovicAHoppinJAEggesbøMLongneckerMPDeterminants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women201354748410.1016/j.envint.2012.12.014Open DOISearch in Google Scholar
Russell MH, Waterland RL, Wong F. Calculation of chemical elimination half-life from blood with an ongoing exposure source: The example of perfluorooctanoic acid (PFOA). Chemosphere 2015;129:210–6. doi: 10.1016/j.chemosphere.2014.07.061RussellMHWaterlandRLWongFCalculation of chemical elimination half-life from blood with an ongoing exposure source: The example of perfluorooctanoic acid (PFOA)2015129210610.1016/j.chemosphere.2014.07.061Open DOISearch in Google Scholar
Legler J, Hamers T, van E van der S de Bor M, Schoeters G, van der Ven L, Eggesbo M, Koppe J, Feinberg M, Trnovec T. The OBELIX project: early life exposure to endocrine disruptors and obesity. Am J Clin Nutr 2011;94:1933S–8S. doi: 10.3945/ajcn.110.001669LeglerJHamersTvanE van der S de Bor MSchoetersGvander Ven LEggesboMKoppeJFeinbergMTrnovecTThe OBELIX project: early life exposure to endocrine disruptors and obesity2011941933S810.3945/ajcn.110.001669Open DOISearch in Google Scholar
Heindel JJ, Newbold R, Schug TT. Endocrine disruptors and obesity. Nat Rev Endocrinol 2015;11:653–61. doi: 10.1038/nrendo.2015.163HeindelJJNewboldRSchugTTEndocrine disruptors and obesity2015116536110.1038/nrendo.2015.163Open DOISearch in Google Scholar
Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28:1057–68. doi: 10.1038/nbt.1685PortelaAEstellerMEpigenetic modifications and human disease20102810576810.1038/nbt.1685Open DOISearch in Google Scholar
Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011;21:381–95. doi: 10.1038/cr.2011.22BannisterAJKouzaridesTRegulation of chromatin by histone modifications2011213819510.1038/cr.2011.22Open DOISearch in Google Scholar
Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006;15:R17–29. doi: 10.1093/hmg/ddl046MattickJSMakuninIVNon-coding RNA200615R172910.1093/hmg/ddl046Open DOISearch in Google Scholar
Razin A, Riggs AD. DNA methylation and gene function. Science 1980;210:604–10. doi: 10.1126/science.6254144RazinARiggsADDNA methylation and gene function19802106041010.1126/science.6254144Open DOISearch in Google Scholar
Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005;6:597–610. doi: 10.1038/nrg1655RobertsonKDDNA methylation and human disease2005659761010.1038/nrg1655Open DOISearch in Google Scholar
Kass SU, Pruss D, Wolffe AP. How does DNA methylation repress transcription? Trends Genet 1997;13:444–9. doi: 10.1016/S0168-9525(97)01268-7KassSUPrussDWolffeAPHow does DNA methylation repress transcription?199713444910.1016/S0168-9525(97)01268-7Open DOISearch in Google Scholar
Suvà ML, Riggi N, Bernstein BE. Epigenetic reprogramming in cancer. Science 2013;339:1567–70. doi: 10.1126/science.1230184SuvàMLRiggiNBernsteinBEEpigenetic reprogramming in cancer201333915677010.1126/science.1230184382155623539597Open DOISearch in Google Scholar
Janesick AS, Shioda T, Blumberg B. Transgenerational inheritance of prenatal obesogen exposure. Mol Cell Endocrinol 2014;398:31–5. doi: 10.1016/j.mce.2014.09.002JanesickASShiodaTBlumbergBTransgenerational inheritance of prenatal obesogen exposure201439831510.1016/j.mce.2014.09.002426262525218215Open DOISearch in Google Scholar
Guerrero-Preston R, Goldman LR, Brebi-Mieville P, Ili-Gangas C, LeBron C, Witter FR, Apelberg BJ, Hernández-Roystacher M, Jaffe A, Halden RU, Sidransky D. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 2010;5:539–46. doi: 10.4161/epi.5.6.12378Guerrero-PrestonRGoldmanLRBrebi-MievillePIli-GangasCLeBronCWitterFRApelbergBJHernández-RoystacherMJaffeAHaldenRUSidranskyDGlobal DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds201055394610.4161/epi.5.6.12378332249520523118Open DOISearch in Google Scholar
Ma Y, Yang J, Wan Y, Peng Y, Ding S, Li Y, Xu B, Chen X, Xia W, Ke Y, Xu S. Low-level perfluorooctanoic acid enhances 3 T3-L1 preadipocyte differentiation via altering peroxisome proliferator activated receptor gamma expression and its promoter DNA methylation. J Anal Toxicol 2018;38:398–407. doi: 10.1002/jat.3549MaYYangJWanYPengYDingSLiYXuBChenXXiaWKeYXuSLow-level perfluorooctanoic acid enhances 3 T3-L1 preadipocyte differentiation via altering peroxisome proliferator activated receptor gamma expression and its promoter DNA methylation20183839840710.1002/jat.354929094436Open DOISearch in Google Scholar
Wen Y, Mirji N, Irudayaraj J. Epigenetic toxicity of PFOA and GenX in HepG2 cells and their role in lipid metabolism. Toxicology in Vitro 2020;65:104797. doi: 10.1016/j.tiv.2020.104797WenYMirjiNIrudayarajJEpigenetic toxicity of PFOA and GenX in HepG2 cells and their role in lipid metabolism20206510479710.1016/j.tiv.2020.10479732068100Open DOISearch in Google Scholar
Belsham DD, Cai F, Cui H, Smukler SR, Salapatek AM, Shkreta L. Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology 2004;145:393–400. doi: 10.1210/en.2003-0946BelshamDDCaiFCuiHSmuklerSRSalapatekAMShkretaLGeneration of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders200414539340010.1210/en.2003-094614551229Open DOISearch in Google Scholar
AAT Bioquest. IC50 calculator, version 1 [displayed 25 june 2021]. Available at https://www.aatbio.com/tools/ic50-calculator-v1AAT BioquestAvailable athttps://www.aatbio.com/tools/ic50-calculator-v1Search in Google Scholar
Hagenaars A, Vergauwen L, Benoot D, Laukens K, Knapen D. Mechanistic toxicity study of perfluorooctanoic acid in zebrafish suggests mitochondrial dysfunction to play a key role in PFOA toxicity. Chemosphere 2013;91:844–56. doi: 10.1016/j.chemosphere.2013.01.056HagenaarsAVergauwenLBenootDLaukensKKnapenDMechanistic toxicity study of perfluorooctanoic acid in zebrafish suggests mitochondrial dysfunction to play a key role in PFOA toxicity2013918445610.1016/j.chemosphere.2013.01.05623427857Open DOISearch in Google Scholar
Peng S, Yan L, Zhang J, Wang Z, Tian M, Shen H. An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid. J Pharm Biomed Anal 2013;86:56–64. doi: 10.1016/j.jpba.2013.07.014PengSYanLZhangJWangZTianMShenHAn integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid20138656–6410.1016/j.jpba.2013.07.01423978341Open DOISearch in Google Scholar
Yan S, Zhang H, Zheng F, Sheng N, Guo X, Dai J. Perfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in mice. Sci Rep 2015;5:11029. doi: 10.1038/srep11029YanSZhangHZhengFShengNGuoXDaiJPerfluorooctanoic acid exposure for 28 days affects glucose homeostasis and induces insulin hypersensitivity in mice201551102910.1038/srep11029446428626066376Open DOISearch in Google Scholar
Liu W, Irudayaraj J. Perfluorooctanoic acid (PFOA) exposure inhibits DNA methyltransferase activities and alters constitutive heterochromatin organization. Food Chem Toxicol 2020;141:111358. doi: 10.1016/j.fct.2020.111358LiuWIrudayarajJPerfluorooctanoic acid (PFOA) exposure inhibits DNA methyltransferase activities and alters constitutive heterochromatin organization202014111135810.1016/j.fct.2020.11135832315686Open DOISearch in Google Scholar
Pierozan P, Jerneren F, Karlsson O. Perfluorooctanoic acid (PFOA) exposure promotes proliferation, migration and invasion potential in human breast epithelial cells. Arch Toxicol 2018;92:1729–39. doi: 10.1007/s00204-018-2181-4PierozanPJernerenFKarlssonOPerfluorooctanoic acid (PFOA) exposure promotes proliferation, migration and invasion potential in human breast epithelial cells20189217293910.1007/s00204-018-2181-4596262129502166Open DOISearch in Google Scholar
Mignard V, Lalier L, Paris F, Vallette FM. Bioactive lipids and the control of Bax pro-apoptotic activity. Cell Death Dis 2014;5:e1266. doi: 10.1038/cddis.2014.226MignardVLalierLParisFValletteFMBioactive lipids and the control of Bax pro-apoptotic activity20145e126610.1038/cddis.2014.226404788024874738Open DOISearch in Google Scholar
Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, Slack RS. Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons. J Neurosci 1999;19:7860–9. doi: 10.1523/JNEUROSCI.19-18-07860.1999CreganSPMacLaurinJGCraigCGRobertsonGSNicholsonDWParkDSSlackRSBax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons1999197860910.1523/JNEUROSCI.19-18-07860.1999Open DOISearch in Google Scholar
Jost CA, Marin MC, Kaelin Jr WG. p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997;389:191–4. doi: 10.1038/38298JostCAMarinMCKaelinJr WGp73 is a simian [correction of human] p53-related protein that can induce apoptosis1997389191410.1038/382989296498Open DOISearch in Google Scholar
Stiewe T, Pützer BM. p73 in apoptosis. Apoptosis 2001;6:447–52. doi: 10.1023/a:1012433522902StieweTPützerBMp73 in apoptosis20016447–5210.1023/a:1012433522902Open DOISearch in Google Scholar
Warita K, Mitsuhashi T, Hoshi N, Ohta K, Suzuki S, Takeuchi Y, Miki T. A unique pattern of bisphenol A effects on nerve growth factor gene expression in embryonic mouse hypothalamic cell line N-44. Arh Hig Rada Toksikol 2014;65:293–9. doi: 10.2478/10004-1254-65-2014-2494WaritaKMitsuhashiTHoshiNOhtaKSuzukiSTakeuchiYMikiTA unique pattern of bisphenol A effects on nerve growth factor gene expression in embryonic mouse hypothalamic cell line N-44201465293910.2478/10004-1254-65-2014-249425205691Open DOISearch in Google Scholar
Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992;11:961–71. PMCID: PMC556537PaganoMPepperkokRVerdeFAnsorgeWDraettaGCyclin A is required at two points in the human cell cycle19921196171PMCID: PMC55653710.1002/j.1460-2075.1992.tb05135.x5565371312467Search in Google Scholar
Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995;15:2612–24. doi: 10.1128/mcb.15.5.2612OhtsuboMTheodorasAMSchumacherJRobertsJMPaganoMHuman cyclin E, a nuclear protein essential for the G1-to-S phase transition19951526122410.1128/mcb.15.5.26122304917739542Open DOISearch in Google Scholar
Brown NR, Lowe ED, Petri E, Skamnaki V, Antrobus R, Johnson L. Cyclin B and cyclin A confer different substrate recognition properties on CDK2. Cell Cycle 2007;6:1350–9. doi: 10.4161/cc.6.11.4278BrownNRLoweEDPetriESkamnakiVAntrobusRJohnsonLCyclin B and cyclin A confer different substrate recognition properties on CDK2200761350910.4161/cc.6.11.427817495531Open DOISearch in Google Scholar
Buhrke T, Krüger E, Pevny S, Rößler M, Bitter K, Lampen A. Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes. Toxicology 2015;333:53–62. doi: 10.1016/j.tox.2015.04.004BuhrkeTKrügerEPevnySRößlerMBitterKLampenAPerfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes2015333536210.1016/j.tox.2015.04.00425868421Open DOISearch in Google Scholar
Engeland K. Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM. Cell Death Differ 2018;25:114–32. doi: 10.1038/cdd.2017.172EngelandKCell cycle arrest through indirect transcriptional repression by p53: I have a DREAM2018251143210.1038/cdd.2017.172Open DOISearch in Google Scholar
Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 2000;97:4291–6. doi: 10.1073/pnas.97.8.4291ChangBDWatanabeKBroudeEVFangJPooleJCKalinichenkoTVRoninsonIBEffects of p21Waf1/Cip1/Sdi1 on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases2000974291610.1073/pnas.97.8.4291Open DOISearch in Google Scholar
Ferrandiz N, Caraballo JM, Garcia-Gutierrez L, Devgan V, Rodriguez-Paredes M, Lafita MC, Bretones G, Quintanilla A, Munoz-Alonso MJ, Blanco R, Reyes JC, Agell N, Delgado MD, Dotto GP, León J. p21 as a transcriptional co-repressor of S-phase and mitotic control genes. PLoS ONE 2012;7:e37759. doi: 10.1371/journal.pone.0037759FerrandizNCaraballoJMGarcia-GutierrezLDevganVRodriguez-ParedesMLafitaMCBretonesGQuintanillaAMunoz-AlonsoMJBlancoRReyesJCAgellNDelgadoMDDottoGPLeónJp21 as a transcriptional co-repressor of S-phase and mitotic control genes20127e3775910.1371/journal.pone.0037759Open DOISearch in Google Scholar
Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369:574–8. doi: 10.1038/369574a0WagaSHannonGJBeachDStillmanBThe p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA1994369574810.1038/369574a0Open DOISearch in Google Scholar
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701–4. doi: 10.1038/366701a0XiongYHannonGJZhangHCassoDKobayashiRBeachDp21 is a universal inhibitor of cyclin kinases1993366701410.1038/366701a0Open DOISearch in Google Scholar
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805–16. doi: 10.1016/0092-8674(93)90499-GHarperJWAdamiGRWeiNKeyomarsiKElledgeSJThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases1993758051610.1016/0092-8674(93)90499-GOpen DOISearch in Google Scholar
De Santi M, Galluzzi L, Lucarini S, Paoletti MF, Fraternale A, Duranti A, De Marco C, Fanelli M, Zaffaroni N, Brandi G, Magnani M. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines. Breast Cancer Res 2011;13:R33. doi: 10.1186/bcr2855DeSanti MGalluzziLLucariniSPaolettiMFFraternaleADurantiADeMarco CFanelliMZaffaroniNBrandiGMagnaniMThe indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines201113R3310.1186/bcr2855321919621435243Open DOISearch in Google Scholar
Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B, Barnett GH. WAF1/CIP1 increases the susceptibility of p53 nonfunctional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 1996;13:1279–85. PMID: 8808702KondoSBarnaBPKondoYTanakaYCaseyGLiuJMorimuraTKaakajiRPetersonJWWerbelBBarnettGHWAF1/CIP1 increases the susceptibility of p53 nonfunctional malignant glioma cells to cisplatin-induced apoptosis199613127985PMID: 8808702Search in Google Scholar
Kreis NN, Sommer K, Sanhaji M, Kramer A, Matthess Y, Kaufmann M, Strebhardt K, Yuan J. Long-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21WAF1/CIP1. Cell Cycle 2009;8:460–72. doi: 10.4161/cc.8.3.7651KreisNNSommerKSanhajiMKramerAMatthessYKaufmannMStrebhardtKYuanJLong-term downregulation of Polo-like kinase 1 increases the cyclin-dependent kinase inhibitor p21WAF1/CIP1200984607210.4161/cc.8.3.765119177004Open DOISearch in Google Scholar
Hempstead BL. Dissecting the diverse actions of pro- and mature neurotrophins. Curr Alzheimer Res 2006;3:19–24. doi: 10.2174/156720506775697061HempsteadBLDissecting the diverse actions of pro- and mature neurotrophins20063192410.2174/15672050677569706116472198Open DOISearch in Google Scholar
Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006;29:1545–64. doi: 10.1098/rstb.2006.1894Reichardt LFNeurotrophin-regulated signalling pathways20062915456410.1098/rstb.2006.1894166466416939974Open DOISearch in Google Scholar
Davey F, Davies AM. TrkB signalling inhibits p75-mediated apoptosis induced by nerve growth factor in embryonic proprioceptive neurons. Curr Biol 1998;8:915–8. doi: 10.1016/s0960-9822(07)00371-5DaveyFDaviesAMTrkB signalling inhibits p75-mediated apoptosis induced by nerve growth factor in embryonic proprioceptive neurons19988915810.1016/s0960-9822(07)00371-5Open DOISearch in Google Scholar
Miller FD, Kaplan DR. Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 2001;58:1045–53. doi: 10.1007/PL00000919MillerFDKaplanDRNeurotrophin signalling pathways regulating neuronal apoptosis20015810455310.1007/PL0000091911529497Open DOISearch in Google Scholar
Warita K, Mitsuhashi T, Ohta K, Suzuki S, Hoshi N, Miki T, Takeuchi Y. In vitro evaluation of gene expression changes for gonadotropin-releasing hormone 1, brain-derived neurotrophic factor and neurotrophic tyrosine kinase, receptor, type 2, in response to bisphenol a treatment. Congenit Anom (Kyoto) 2013 ; 53 : 42–5. doi : 10.1111/j.1741-4520.2012.00381.xWaritaKMitsuhashiTOhtaKSuzukiSHoshiNMikiTTakeuchiYIn vitro evaluation of gene expression changes for gonadotropin-releasing hormone 1, brain-derived neurotrophic factor and neurotrophic tyrosine kinase, receptor, type 2, in response to bisphenol a treatment20135342–510.1111/j.1741-4520.2012.00381.x23185968Open DOISearch in Google Scholar
Cheow LF, Courtois ET, Tan Y, Viswanathan R, Xing Q, Tan RZ, Tan DSW, Robson P, Loh Y, Quake SR, Burkholder WF. Single-cell multimodal profiling reveals cellular epigenetic heterogeneity. Nat Methods 2016;13:833–6. doi: 10.1038/nmeth.3961CheowLFCourtoisETTanYViswanathanRXingQTanRZTanDSWRobsonPLohYQuakeSRBurkholderWFSingle-cell multimodal profiling reveals cellular epigenetic heterogeneity201613833610.1038/nmeth.396127525975Open DOISearch in Google Scholar
Cusanovich DA, Hill AJ, Aghamirzaie D, Daza RM, Pliner HA, Berletch JB, Filippova GN, Huang X, Christiansen L, DeWitt WS, Lee C, Regalado SG, Read DF, Steemers FJ, Disteche CM, Trapnell C, Shendure J. A single-cell atlas of in vivo mammalian chromatin accessibility. Cell 2018;174:1309–24. doi: 10.1016/j.cell.2018.06.052CusanovichDAHillAJAghamirzaieDDazaRMPlinerHABerletchJBFilippovaGNHuangXChristiansenLDeWittWSLeeCRegaladoSGReadDFSteemersFJDistecheCMTrapnellCShendureJA single-cell atlas of in vivo mammalian chromatin accessibility201817413092410.1016/j.cell.2018.06.052615830030078704Open DOISearch in Google Scholar
Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998;19:187–91 doi: 10.1038/561JonesPLVeenstraGJWadePAVermaakDKassSULandsbergerNStrouboulisJWolffeAPMethylated DNA and MeCP2 recruit histone deacetylase to repress transcription1998191879110.1038/5619620779Open DOISearch in Google Scholar
Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008;320:1224–9. doi: 10.1126/science.1153252ChahrourMJungSYShawCZhouXWongSTQinJZoghbiHYMeCP2, a key contributor to neurological disease, activates and represses transcription20083201224910.1126/science.1153252244378518511691Open DOISearch in Google Scholar